Details for Patent: 9,527,833

✉ Email this page to a colleague

Which drugs does patent 9,527,833 protect, and when does it expire?

Patent 9,527,833 protects LONSURF and is included in one NDA.

This patent has forty-seven patent family members in twenty-nine countries.

Summary for Patent: 9,527,833

Title:	Stable crystal form of tipiracil hydrochloride and crystallization method for the same
Abstract:	An objective of the present invention is to obtain a stable crystal form of 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione hydrochloride. The present invention provides a crystal of 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione hydrochloride exhibiting characteristic peaks at angles of 11.6.degree., 17.2.degree., 17.8.degree., 23.3.degree., 27.1.degree., and 29.3.degree. as a diffraction angle (2.theta..+-.0.1.degree.) in powder X-ray diffraction.
Inventor(s):	Kazuno; Hideki (Ibaraki, JP), Mutsumi; Tomonobu (Saitama, JP)
Assignee:	TAIHO PHARMACEUTICAL CO., LTD. (Tokyo, JP)
Application Number:	14/896,748
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,527,833
Patent Claim Types: see list of patent claims	Compound; Composition; Use; Formulation;

Drugs Protected by US Patent 9,527,833

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Taiho Oncology	LONSURF	tipiracil hydrochloride; trifluridine	TABLET;ORAL	207981-001	Sep 22, 2015	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y	Y			⤷ Sign Up
Taiho Oncology	LONSURF	tipiracil hydrochloride; trifluridine	TABLET;ORAL	207981-002	Sep 22, 2015	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,527,833

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2013-126567	Jun 17, 2013

PCT Information
PCT Filed	June 17, 2014	PCT Application Number:	PCT/JP2014/065985
PCT Publication Date:	December 24, 2014	PCT Publication Number:	WO2014/203877

International Family Members for US Patent 9,527,833

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014282281	⤷ Sign Up
Australia	2017208215	⤷ Sign Up
Australia	2018219967	⤷ Sign Up
Brazil	112015031619	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.